Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123536054 | 12353605 | 4 | F | 201412 | 20160719 | 20160511 | 20160801 | EXP | GB-CIPLA LTD.-2016GB04792 | CIPLA | 0.00 | Y | 0.00000 | 20160801 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123536054 | 12353605 | 1 | PS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Unknown | UNK | Y | U | 206367 | ||||||||
| 123536054 | 12353605 | 2 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 2.5 MG, QD | 80 | MG | Y | U | 0 | 2.5 | MG | TABLET | QD | ||
| 123536054 | 12353605 | 3 | SS | Calcium channel blockers | UNSPECIFIED INGREDIENT | 1 | Unknown | 2.5 MG, QD | Y | U | 0 | 2.5 | MG | TABLET | QD | ||||
| 123536054 | 12353605 | 4 | SS | Natrilix-SR | INDAPAMIDE | 1 | Unknown | 1.5 MG, UNK | 0 | 1.5 | MG | TABLET | |||||||
| 123536054 | 12353605 | 5 | C | Doxazosin mesilate | DOXAZOSIN MESYLATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 123536054 | 12353605 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 20MG IN THE MORNING AND 40MG IN THE EVENING | U | U | 0 | ||||||||
| 123536054 | 12353605 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 20 MG, BID | U | U | 0 | 20 | MG | BID | |||||
| 123536054 | 12353605 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 123536054 | 12353605 | 9 | C | Regurin | 2 | Unknown | UNK | U | U | 0 | |||||||||
| 123536054 | 12353605 | 10 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | 80 MG, QD | U | U | 0 | 80 | MG | QD | |||||
| 123536054 | 12353605 | 11 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123536054 | 12353605 | 1 | Hypertension |
| 123536054 | 12353605 | 2 | Hypertension |
| 123536054 | 12353605 | 3 | Hypertension |
| 123536054 | 12353605 | 4 | Hypertension |
| 123536054 | 12353605 | 5 | Product used for unknown indication |
| 123536054 | 12353605 | 6 | Product used for unknown indication |
| 123536054 | 12353605 | 8 | Product used for unknown indication |
| 123536054 | 12353605 | 9 | Product used for unknown indication |
| 123536054 | 12353605 | 10 | Product used for unknown indication |
| 123536054 | 12353605 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123536054 | 12353605 | LT |
| 123536054 | 12353605 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123536054 | 12353605 | Cerebrovascular accident | |
| 123536054 | 12353605 | Drug ineffective | |
| 123536054 | 12353605 | Glomerular filtration rate decreased | |
| 123536054 | 12353605 | Hypervolaemia | |
| 123536054 | 12353605 | Impaired quality of life | |
| 123536054 | 12353605 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123536054 | 12353605 | 1 | 2015 | 2015 | 0 | |
| 123536054 | 12353605 | 2 | 20141030 | 2015 | 0 | |
| 123536054 | 12353605 | 3 | 20141030 | 2015 | 0 | |
| 123536054 | 12353605 | 4 | 2015 | 0 | ||
| 123536054 | 12353605 | 6 | 20160215 | 20160309 | 0 |